Integrin, laminin, and epidermal growth factor receptor signaling pathways were the most significant altered pathways in young age estrogen receptor-positive breast cancer patients (≤45 years) compared to older age patients [31]. This evidence concerns the gene ESR1 and breast carcinoma.